http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150024651-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f40b30ca35b7bcedbf3fdd6dfa76640 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4bab439d4e28112c6748ff8af437063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f72ad7bddd690c3047dd5880b558ec1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afd39bad17aaf58659458d6b7e4e61af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_247b92b5c9807daef8e6c225ec5d51be |
| publicationDate | 2015-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150024651-A |
| titleOfInvention | Composition for preventing or treating neurodegenerative disease comprising loganin |
| abstract | The present invention relates to a pharmaceutical composition for the prevention or treatment of degenerative neurological diseases comprising rogaine as an active ingredient. The reorganin of the present invention is excellent in the activity of inhibiting Aβ-induced neurotoxicity, and thus can be effectively used for pharmaceutical medicines and functional foods for the prevention or treatment (improvement) of neurodegenerative diseases including Alzheimer's disease. In particular, the roganin of the present invention is a material derived from natural product, which is a natural product, and has stability without cytotoxicity. Therefore, the composition of the present invention containing it as an effective ingredient has safety advantages for long-term use without adverse effect on human body. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101698051-B1 |
| priorityDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.